Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 7.76 SEK -1.77% Market Closed
Market Cap: 371.5m SEK

During the last 3 months Moberg Pharma AB (publ) insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 24% over this period (open performance analysis).

The last transaction was made on Jun 20, 2024 by Nikolaj Arrild Sørensen (Chief Executive Officer) , who bought 144k SEK worth of MOB shares.

Last Transactions:
Nikolaj Arrild Sørensen
Chief Executive Officer
kr+144k
Kerstin Valinder Strinnholm
Member of the Board
kr+278.4k
Mark Beveridge
Chief Financial Officer
kr+2.8k
Mark Beveridge
Chief Financial Officer
kr+2.7k
Mark Beveridge
Chief Financial Officer
kr+4.6k
Cindy Wong
Chief Financial Officer (CFO)
kr+4.9k
Cindy Wong
Chief Financial Officer (CFO)
kr+4.8k
Mark Beveridge
Chief Financial Officer
kr+45.5k
Mark Beveridge
Chief Financial Officer
kr-19.1k
View All Transactions

During the last 3 months Moberg Pharma AB (publ) insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 24% over this period (open performance analysis).

The last transaction was made on Jun 20, 2024 by Nikolaj Arrild Sørensen (Chief Executive Officer) , who bought 144k SEK worth of MOB shares.

Sold
0-3
months
0 SEK
0
3-6
months
0 SEK
0
6-9
months
0 SEK
0
9-12
months
0 SEK
0
Bought
0-3
months
No Insider Transactions
0
0 SEK
3-6
months
No Insider Transactions
0
0 SEK
6-9
months
No Insider Transactions
0
0 SEK
9-12
months
2
422.4k SEK

Moberg Pharma AB (publ)
Insider Trading Chart

Moberg Pharma AB (publ)
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Moberg Pharma AB (publ)
Last Insider Transactions

Global
Insiders Monitor

Moberg Pharma AB (publ)
Glance View

Market Cap
362.3m SEK
Industry
Pharmaceuticals

Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. The company is headquartered in Bromma, Stockholm. The company went IPO on 2011-05-26. Its product portfolio includes products for the treatment of skin diseases and pain, such as Emtrix/Nalox, for the treatment of nails damaged by fungus or psoriasis; Kerasal, for dry and damaged feet, and Kaprolac, a range of products for several types of skin and scalp problems. Additionally, the Company has two projects in phase II of development, namely MOB-15, for the treatment of nail fungus, and Limtop, for the treatment of actinic keratosis, basalioma and genital warts. The firm collaborates with Meda AB, Menarini Group, Perrigo Company, OzHealth Pharma and Zelmic AB, among others. The company is active in more than 35 countries, and operates, among others, through Alterna LLC. The company also owns three Over-The-Counter (OTC) brands in the United States.

MOB Intrinsic Value
23.77 SEK
Undervaluation 67%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top